As of May 29, 2025, Targovax ASA (TRVX.OL) reports a Current Ratio of 2.33.
Current Ratio assesses a company's ability to pay short-term debts by comparing liquid assets to liabilities, with higher ratios signaling better financial health.
Historical Trend of Targovax ASA's Current Ratio
Over recent years, Targovax ASA's Current Ratio has shown significant volatility. The table below summarizes the historical values:
| Date | Current Ratio |
|---|---|
| 2022-12-31 | 2.33 |
| 2021-12-31 | 5.11 |
| 2020-12-31 | 4.96 |
| 2019-12-31 | 1.69 |
| 2018-12-31 | 2.80 |
This slight downward trend highlights how Targovax ASA manages its short-term assets and liabilities over time.
Comparing Targovax ASA's Current Ratio to Peers
To better understand Targovax ASA's position, it's useful to compare its Current Ratio against industry peers. Below are selected comparisons:
| Company | Current Ratio |
|---|---|
| Targovax ASA (TRVX.OL) | 2.33 |
| bioXXmed AG (T5O.DE) | 44.34 |
| E-Therapeutics PLC (ETX.L) | 21.30 |
| Vaccibody AS (VACC.OL) | 17.38 |
| Arcticzymes Technologies ASA (AZT.OL) | 17.12 |
| Evgen Pharma PLC (EVG.L) | 7.36 |
Compared to its competitors, Targovax ASA's Current Ratio is about average compared to peers, reflecting balanced short-term asset management.